Royce & Associates’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,031
Closed -$115K 810
2026
Q1
$115K Buy
+10,031
New +$141K ﹤0.01% 756
2023
Q2
Sell
-17,110
Closed -$112K 951
2023
Q1
$112K Sell
17,110
-1,222
-7% -$4.99K ﹤0.01% 900
2022
Q4
$45.1K Buy
18,332
+2,443
+15% +$7.64K ﹤0.01% 903
2022
Q3
$79K Buy
+15,889
New +$92.7K ﹤0.01% 910

Other funds holding OSCR

Royce & Associates's OSCR Position: Q2 2026 in Review

Royce & Associates sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 10,031 shares — an estimated $115K sold.

Royce & Associates first reported a position in OSCR in Q3 2022 and held it in 4 quarters. The position peaked at $115K in Q1 2026. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Royce & Associates reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
  • Royce & Associates sold 10,031 Oscar Health shares in Q2 2026, an estimated $115K.
  • Royce & Associates first reported a position in Oscar Health in Q3 2022 and held it in 4 quarters.
  • Royce & Associates's Oscar Health position peaked at $115K in Q1 2026.
  • 402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.